Search

Your search keyword '"12"' showing total 119,936 results

Search Constraints

Start Over You searched for: Author "12" Remove constraint Author: "12"
119,936 results on '"12"'

Search Results

752. Understanding the potential contribution of polygenic risk scores to the prediction of gestational and type 2 diabetes in women from British Pakistani and Bangladeshi groups: a cohort study in Genes and Health

754. AUTS2-related syndrome: Insights from a large European cohort

755. Freiburg index of post-TIPS survival (FIPS) identifies patients at risk of further decompensation and ACLF after TIPS

756. Impact of Different Mediastinal Staging Modalities on Target Volume Delineation in Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the Multicenter Randomized PET-Plan Trial

757. Quadrant, necrosis, and infection criteria for the risk stratification of walled-off necrosis: external validation using multi-institutional data

761. Fibroblast growth factor 23 and fibroblast growth factor receptor 4 promote cardiac metabolic remodeling in chronic kidney disease

763. D-dimer after 3 months of anticoagulation therapy and outcomes in cancer-associated isolated distal deep vein thrombosis

764. Infections in Patients with Solid Tumors Undergoing Adoptive Cellular Therapy

765. Evolving epidemiology of HCC in Spain

766. Longitudinal Lipid Trajectories and Progression of CKD in Children

767. Deficiency of T follicular helper cell Tet3 DNA demethylation inhibits pathogenic IgG2c class switching and chronic GVHD

768. Multiomic analysis uncovers a continuous spectrum of differentiation and Wnt-MDK-driven immune evasion in hepatoblastoma

769. Gut microbiome alterations precede graft rejection in kidney transplantation patients

770. Donation after the circulatory determination of death heart transplantation with thoraco-abdominal normothermic regional perfusion and static cold storage: The experience in Spain

772. Preclinical development and clinical safety assessment of a fully synthetic peptide-peptide conjugate built to enable endogenous antibody binding, complex formation, and innate receptor engagement

773. Refractoriness to eltrombopag in adult primary immune thrombocytopenia: utility of next-generation sequencing techniques

774. Characterizing the heterogeneity of Castleman disease and oligocentric subtype: findings from the ACCELERATE registry

775. Outcome of high-grade B-cell lymphoma compared with other large B-cell lymphoma after CAR-T rescue: a DESCAR-T LYSA study

776. Mortality and sequelae associated with regional use of intracranial devices among patients with pneumococcal meningitis: a nationwide, population-based cohort study

778. Extended Risankizumab Treatment in Patients With Crohn’s Disease Who Did Not Achieve Clinical Response to Induction Treatment

779. Molecular testing of lung cancer in Australia: consensus best practice recommendations from the royal college of pathologists of Australasia in collaboration with the thoracic oncology group of Australasia

780. Clinical Decision-Making About Immunosuppressive Treatment in Focal Segmental Glomerulosclerosis

781. Randomized phase 2 study to assess the role of single-agent nivolumab to maintain remission in acute myeloid leukemia

784. Late-onset telomere biology disorders in adults: clinical insights and treatment outcomes from a retrospective registry cohort

788. Extracellular vesicles from the lung pro-thrombotic niche drive cancer-associated thrombosis and metastasis via integrin beta 2

792. Diet and survival after a diagnosis of ovarian cancer: a pooled analysis from the Ovarian Cancer Association Consortium

794. Three-field vs two-field lymphadenectomy in thoracic ESCC patients: a multicenter randomized study (NST 1503)

795. Spectroscopic solutions for generating new global soil information

796. Autologous or Allogeneic Hematopoietic Stem Cell Transplantation as Front-Line Treatment for Adult Secondary Acute Myeloid Leukemia Patients: The PETHEMA Registry Experience

797. Relevance of anti–platelet factor 4/heparin antibodies and platelet activation in systemic inflammatory diseases and thrombosis disorders: insight from the COVID-19 pandemic

799. Long-term outcomes of passive immunotherapy for COVID-19: a pooled analysis of a large multinational platform randomized clinical trial

800. European Myeloma Network Group review and consensus statement on primary plasma cell leukemia

Catalog

Books, media, physical & digital resources